In the present study, we utilize CGA to show that induction of tumor differentiation could down-regulate cancer PD-L1 expression, activate cytotoxic T lymphocytes in tumor tissues, and boost immunotherapy of currently available ICI antibodies in combination. The gene discussed is CD274; the disease is neoplasm.